{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T03:06:27Z","timestamp":1694574387744},"reference-count":28,"publisher":"SLACK, Inc.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Refract Surg"],"published-print":{"date-parts":[[1998,9]]},"abstract":"<jats:p>ABSTRACT<\/jats:p>\n          <jats:p>BACKGROUND: Pentoxifylline (PTX) is a methylxanthine derivative that, besides its hemorrheologic properties, possesses multiple physiologic effects at the cellular level. It has been used in keloid prevention due to its ability to inhibit the secretion of collagen and glycosaminoglycans from activated fibroblasts.<\/jats:p>\n          <jats:p>METHODS: Ten New Zealand White (NZW) rabbits underwent a -7.00 diopters, 6.0 mm diameter photorefractive keratectomy after laser ablation of the epithelium with a VISX 20\/20 excimer laser. The bare stroma was stained with fresh 0.5% dichlorotriazinyl aminofluorescein (DTAF). The procedure was performed on both eyes, 4 days apart. One eye received 1% Pentoxifylline qid and the other balanced salt solution qid as a control for 4 weeks, starting the same day of surgery. Two masked observers graded the amount of haze at 2, 4, 6, and 8 weeks after surgery using slit-lamp biomicroscopy. Three rabbits were sacrificed at 2 and 4 weeks followed by two rabbits at 6 and 8 weeks. The area between the DTAF-stained collagen to the base of the epithelium was measured using a digital image analyzer.<\/jats:p>\n          <jats:p>RESULTS: There was no statistically significant difference in the amount of haze either by slit-lamp microscopy or by histological analysis between the pentoxifylline-treated eyes and the controls at any time interval (Student's f-test: 0.16 to 0.92)<\/jats:p>\n          <jats:p>CONCLUSION: Pentoxifylline did not seem to affect haze formation in a PRK rabbit model. As no signs of toxicity were observed, further studies might examine higher concentrations or dose frequencies. [J Refract Surg 1998;14:567-570]<\/jats:p>","DOI":"10.3928\/1081-597x-19980901-16","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T10:01:51Z","timestamp":1618912911000},"page":"567-570","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of Pentoxifylline in the Prevention of Haze after Photorefractive Keratectomy in the Rabbit"],"prefix":"10.3928","volume":"14","author":[{"given":"Claudia M","family":"Francesconi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Abad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan E","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan H","family":"Talamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"crossref","unstructured":"1. Fantes FE Hanna KD Waring GO Pouliquen Y Thompson KP Savoldelli M. Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. Arch Ophthalmol 1990; 108: 665-675.","DOI":"10.1001\/archopht.1990.01070070051034"},{"key":"e_1_3_1_3_1","doi-asserted-by":"crossref","unstructured":"2. Malley DS Steinert RF Puliafito CA Dobi ET. Immunofluorescence study of corneal wound healing after excimer laser anterior keratectomy in the monkey eye. Arch Ophthalmol 1990;108:1316-1322.","DOI":"10.1001\/archopht.1990.01070110132037"},{"key":"e_1_3_1_4_1","doi-asserted-by":"crossref","unstructured":"3. Talamo JH GoUamudi S Green R De la Cruz Z Filatov V Stark WS. Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Arch Ophthalmol 1991;109:1141-1146.","DOI":"10.1001\/archopht.1991.01080080101040"},{"key":"e_1_3_1_5_1","doi-asserted-by":"crossref","unstructured":"4. O'Brart DPS Lohmann CP Klonos G Corbett MC Pollock WS KeiT-Muir MG Marshall J. The effects of topical corticosteroids and plasmi ? inhibitors on refractive outcome haze and visual performance after photorefractive keratectomy. Ophthalmology 1994; 101:1565-1574.","DOI":"10.1016\/S0161-6420(94)38032-8"},{"key":"e_1_3_1_6_1","doi-asserted-by":"crossref","unstructured":"5. Binder PS Anderson JA Rock ME Vrabec MP. Human excimer laser keratectomy. Clinical and histopathologic correlations. Ophthalmology 1994;101:979-989.","DOI":"10.1016\/S0161-6420(94)31202-4"},{"key":"e_1_3_1_7_1","doi-asserted-by":"crossref","unstructured":"6. Fagerholm P Hamberg-Nystrom H Tengroth B Epstein D. Effect of postoperative steroids on the outcome of photorefractive keratectomy for myopia with the Summit excimer laser. J Cataract Refract Surg 1994;20(suppl):212-215.","DOI":"10.1016\/S0886-3350(13)80755-9"},{"key":"e_1_3_1_8_1","doi-asserted-by":"crossref","unstructured":"7. Corbett MC O'Brart DP Marshall J. Do topical corticosteroids have a role following excimer laser photorefractive keratectomy? J Refract Surg 1995;11:380-387.","DOI":"10.3928\/1081-597X-19950901-15"},{"key":"e_1_3_1_9_1","doi-asserted-by":"crossref","unstructured":"8. Nassaralla B Szerenyi K Wang X Reaves TA McDonnell P. Effect of diclofenac on corneal haze after photorefractive keratectomy in rabbits. Ophthalmology 1995;102:469-474.","DOI":"10.1016\/S0161-6420(95)30998-0"},{"key":"e_1_3_1_10_1","unstructured":"9. Rieck P David T Hartmann C Renard G Courtois Y Pouliquen Y. Basic fibroblast growth factor modulates corneal wound healing after excimer laser keratomileusis in rabbits. Ger J Ophthalmol 1994;3:105-111."},{"key":"e_1_3_1_11_1","doi-asserted-by":"crossref","unstructured":"10. Lohmann CP Marshall J. Plasmin- and plasminogen-activator inhibitors after excimer laser photorefractive keratectomy: new concept in prevention of postoperative myopic regression and haze. Refract Corneal Surg 1993;9:300-302.","DOI":"10.3928\/1081-597X-19930701-12"},{"key":"e_1_3_1_12_1","doi-asserted-by":"crossref","unstructured":"11. Gillies MC Garrett SKM Shina SM Morlet N Taylor HR. Topical interpheron alpha 2b for corneal haze after excimer laser photorefractive keratectomy. J Cataract Refract Surg 1996;22:891-900.","DOI":"10.1016\/S0886-3350(96)80188-X"},{"key":"e_1_3_1_13_1","doi-asserted-by":"crossref","unstructured":"12. Samlaska CP Winfield EA. Pentoxifylline: clinical review. J Am Acad Dermatol 1994:30:603-621.","DOI":"10.1016\/S0190-9622(94)70069-9"},{"key":"e_1_3_1_14_1","doi-asserted-by":"crossref","unstructured":"13. Berman B Duncan MR. Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid scleroderma and morphea skin and their production of collagen glycosaminoglycans and fibronectin. Br J Dermatol 1990;123:339-346.","DOI":"10.1111\/j.1365-2133.1990.tb06294.x"},{"key":"e_1_3_1_15_1","doi-asserted-by":"crossref","unstructured":"14. Berman B Duncan MR. Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation collagen glycosaminoglycan and fibronectin production and increases collagenase activity. J Invest Dermatol 1989;92:605-610.","DOI":"10.1111\/1523-1747.ep12712140"},{"key":"e_1_3_1_16_1","doi-asserted-by":"crossref","unstructured":"15. Duncan MR Hasan A Berman B. Pentoxifylline pentifylline. and interferons decrease type I and III procollagen mRNA levels in dermal fibroblasts: evidence for mediation by nuclear factor 1 down-regulation. J Invest Dermatol 1995;104:1-5.","DOI":"10.1111\/1523-1747.ep12612819"},{"key":"e_1_3_1_17_1","unstructured":"16. Davison PF Galbavy EJ. Connective tissue remodeling in corneal and scleral wounds. Invest Ophthalmol Vis Sci 1986;27:1478-1484."},{"key":"e_1_3_1_18_1","doi-asserted-by":"crossref","unstructured":"17. Auffarth GU Wesendahl TA Solomon KD1 Brown SJ Apple DJ A modified preparation technique for closed-system ocular surgery of human eyes obtained postmortem. Ophthalmology 1996;103:977-982.","DOI":"10.1016\/S0161-6420(96)30576-9"},{"key":"e_1_3_1_19_1","doi-asserted-by":"crossref","unstructured":"18. Ely H. Pentoxifylline therapy in dermatology: a review of localized hyperviscosity and its effects on the skin. Dermatol Clin 1988;6:585-608.","DOI":"10.1016\/S0733-8635(18)30637-5"},{"key":"e_1_3_1_20_1","unstructured":"19. Schoenharting M Musikic P Mueller R. The haemorheological and antithrombotic potential of pentoxifylline (\"Trental\"): a review. Pharmatherapeutica 1988;5:159-169."},{"key":"e_1_3_1_21_1","unstructured":"20. Ambrus JL Halpern J Mahafzah M Sayyid S. Platelet aggregation in septic shock: effect of pentoxifylline. J Med 1990;21:121-128."},{"key":"e_1_3_1_22_1","doi-asserted-by":"crossref","unstructured":"21. Quagliarello V Sheld WM. Bacterial meningitis: pathogenesis pathophysiology and progress. N Engl J Med 1992;327:864-872.","DOI":"10.1056\/NEJM199209173271208"},{"key":"e_1_3_1_23_1","unstructured":"22. Chang CC Wu YC Chi\u00f9 HC Liu YL Lu YC. Pentoxifylline inhibits the proliferation of human fibroblasts derived from normal hypertrophic scar and keloid skin and their mitochondrial activity and collagen synthesis. Eur J Dermatol 1991;1:214-220. '"},{"key":"e_1_3_1_24_1","doi-asserted-by":"crossref","unstructured":"23. Chang CC Chang TC Kao SCS Kuo YF Chien LF. Pentoxifylline inhibits the proliferation and glycosaminoglycan synthesis of cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial myxoedema. Acta Endocrinol 1993;129:322-327.","DOI":"10.1530\/acta.0.1290322"},{"key":"e_1_3_1_25_1","doi-asserted-by":"crossref","unstructured":"24. Rawe IM Zabel RW Tuft SJ Chen V Meek KM. A morphological study of rabbit corneas after laser keratectomy. Eye 1992;6:637-642.","DOI":"10.1038\/eye.1992.137"},{"key":"e_1_3_1_26_1","doi-asserted-by":"crossref","unstructured":"25. Corbett MC Prydal JI Verma S Oliver KM Pande M Marshal J An in vivo investigation of the structures responsible for corneal haze after photorefractive keratectomy and their effect on visual function. Ophthalmology 1996;103:1366-1380.","DOI":"10.1016\/S0161-6420(96)30495-8"},{"key":"e_1_3_1_27_1","unstructured":"26. Lohmann C Gartry D Kerr-Muir M Timberlake G Fitzke F Marshall J. Haze in photorefractive keratectomy: its origins and consequences. Lasers and Light in Ophthalmology 1991;4:15-34."},{"key":"e_1_3_1_28_1","unstructured":"27. Tuft SJ Zabel RW Marshall J Corneal repair following keratectomy. A comparison between conventional surgery and laser photoablation. Invest Ophthalmol Vis Sci 1989;30:1769-1777."},{"key":"e_1_3_1_29_1","doi-asserted-by":"crossref","unstructured":"28. Ely H. Is pentoxifylline the drug of the decade? J Am Acad Dermatol 1994;30:639-642.","DOI":"10.1016\/S0190-9622(09)80111-4"}],"container-title":["Journal of Refractive Surgery"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T10:04:36Z","timestamp":1683108276000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/1081-597X-19980901-16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["10.3928\/1081-597X-19980901-16"],"URL":"https:\/\/doi.org\/10.3928\/1081-597x-19980901-16","relation":{},"ISSN":["1081-597X"],"issn-type":[{"value":"1081-597X","type":"print"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}